← All Sponsors

SPONSOR

Nanjing First Hospital, Nanjing Medical University

Total Trials

8

Recruiting

8

Phases

N/A

Conditions studied: Head and Neck Tumor Lung Cancer Pancreatic Cancer Aortic Valve Disease Pulmonary Arterial Hypertension Prediabetes Acute Coronary Syndrome Hyperlipidemias Percutaneous Coronary Intervention Cardiovascular Events

99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

Head and Neck Tumor

Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation

Aortic Valve Disease

Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Effects of Coffee Consumption on Metabolic Markers in Adults With Prediabetes and Obesity

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

Acute Coronary Syndrome

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Recombinant Human Thyroid Stimulating Hormone

TAVR for Aortic Valve Disease

Aortic Valve Disease

IVI-guided Versus Angiography-guided PCI in Patients With Diabetes Mellitus